W.R. Berkley Corp’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

W.R. Berkley Corp’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-278,620	Closed	-$2.82M	–	400
2022 Q3	$2.82M	Buy	278,620 +80,800	+41%	+$816K	0.14%	143
2022 Q2	$1.99M	Hold	197,820	–	–	0.1%	199
2022 Q1	$1.98M	Hold	197,820	–	–	0.1%	207
2021 Q4	$1.97M	Buy	+197,820	New	+$1.96M	0.11%	213

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

W.R. Berkley Corp's ARCK Position: Q4 2022 in Review

W.R. Berkley Corp sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 278,620 shares — an estimated $2.82M sold.

W.R. Berkley Corp first reported a position in ARCK in Q4 2021 and held it in 4 quarters. The position peaked at $2.82M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

W.R. Berkley Corp reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
W.R. Berkley Corp sold 278,620 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $2.82M.
W.R. Berkley Corp first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
W.R. Berkley Corp's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $2.82M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on W.R. Berkley Corp's 13F filing for Q4 2022, filed 14 Feb 2023.